Recruiting NA INTERVENTIONAL 2-arm NCT06643286

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma (Melanoma SCP)

Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App

Sponsor: Albert Schweitzer Hospital

Conditions Melanoma (Skin) Melanoma Stage Melanoma, Stage II, Stage I Survivorship

Interventions Digizorg Melanoma app

Updated 3 times since 2024 Last updated: Jun 6, 2025 Started: Apr 1, 2025 Primary completion: Sep 1, 2026 Completion: Dec 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06643286, this NA trial focuses on Melanoma (Skin) and Melanoma Stage and remains actively recruiting participants. Sponsored by Albert Schweitzer Hospital, it has been updated 3 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Jul 2025 — Present [monthly]

Recruiting NA
May 2025 — Jul 2025 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2024 — May 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Albert Schweitzer Hospital
BeterKeten
Erasmus Medical Center
Franciscus Gasthuis
Maasstad Hospital

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dordrecht, Netherlands
• Rotterdam, Netherlands